Sára Tóth

2.3k total citations
58 papers, 1.9k citations indexed

About

Sára Tóth is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Sára Tóth has authored 58 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 25 papers in Immunology and 19 papers in Oncology. Recurrent topics in Sára Tóth's work include Mast cells and histamine (13 papers), Cytokine Signaling Pathways and Interactions (11 papers) and Polyamine Metabolism and Applications (6 papers). Sára Tóth is often cited by papers focused on Mast cells and histamine (13 papers), Cytokine Signaling Pathways and Interactions (11 papers) and Polyamine Metabolism and Applications (6 papers). Sára Tóth collaborates with scholars based in Hungary, United Kingdom and United States. Sára Tóth's co-authors include András Falus, Hargita Hegyesi, Eszter Lázár‐Molnár, Peter D. Rathjen, Austin Smith, Zoltán Wiener, Anthony C. Willis, John K. Heath, Péter Igaz and Krisztina Hegyi and has published in prestigious journals such as Cell, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

Sára Tóth

57 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sára Tóth Hungary 21 948 644 514 262 161 58 1.9k
Karsten Jürchott Germany 24 1.7k 1.8× 463 0.7× 628 1.2× 272 1.0× 165 1.0× 48 2.6k
Toru Tanaka Japan 30 1.6k 1.6× 429 0.7× 415 0.8× 363 1.4× 280 1.7× 89 2.9k
Gautam Adhikary United States 30 1.2k 1.3× 252 0.4× 383 0.7× 261 1.0× 215 1.3× 69 2.2k
Lazaros C. Foukas United Kingdom 18 1.4k 1.5× 347 0.5× 306 0.6× 141 0.5× 185 1.1× 25 2.0k
Masahito Matsumoto Japan 24 1.6k 1.7× 695 1.1× 961 1.9× 469 1.8× 119 0.7× 56 2.6k
Xuejie Wang China 21 933 1.0× 502 0.8× 740 1.4× 252 1.0× 120 0.7× 49 2.0k
Danielle L. Krebs Canada 21 1.1k 1.1× 1.3k 2.0× 1.4k 2.7× 343 1.3× 158 1.0× 31 2.9k
Osvaldo Rey United States 29 1.6k 1.7× 250 0.4× 320 0.6× 132 0.5× 197 1.2× 57 2.4k
Michele C. Madigan Australia 38 1.6k 1.6× 515 0.8× 302 0.6× 264 1.0× 115 0.7× 142 4.1k
Nassim Ghaffari‐Tabrizi‐Wizsy Austria 23 968 1.0× 603 0.9× 283 0.6× 309 1.2× 101 0.6× 58 2.1k

Countries citing papers authored by Sára Tóth

Since Specialization
Citations

This map shows the geographic impact of Sára Tóth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sára Tóth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sára Tóth more than expected).

Fields of papers citing papers by Sára Tóth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sára Tóth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sára Tóth. The network helps show where Sára Tóth may publish in the future.

Co-authorship network of co-authors of Sára Tóth

This figure shows the co-authorship network connecting the top 25 collaborators of Sára Tóth. A scholar is included among the top collaborators of Sára Tóth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sára Tóth. Sára Tóth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tóth, Sára, et al.. (2024). Unlocking Oxetane Potential: Modular Synthetic Platform for the Concise Synthesis of Acyclic Oligo‐Isoprenoids and Terpenoids. Angewandte Chemie International Edition. 64(4). e202416441–e202416441. 1 indexed citations
2.
Németh, Andrea H., Norbert Orgován, Barbara W. Sódar, et al.. (2017). Antibiotic-induced release of small extracellular vesicles (exosomes) with surface-associated DNA. Scientific Reports. 7(1). 8202–8202. 114 indexed citations
3.
Pál, Zsuzsanna, Péter Antal, Gábor Hullám, et al.. (2010). A novel galectin-1 and interleukin 2 receptor β haplotype is associated with autoimmune myasthenia gravis. Journal of Neuroimmunology. 229(1-2). 107–111. 14 indexed citations
4.
Pós, Zoltán, Zoltán Wiener, Péter Pócza, et al.. (2008). Histamine Suppresses Fibulin-5 and Insulin-like Growth Factor-II Receptor Expression in Melanoma. Cancer Research. 68(6). 1997–2005. 16 indexed citations
5.
Hegyi, Krisztina, András Falus, & Sára Tóth. (2007). Elevated CREB activity in embryonic fibroblasts of gene-targeted histamine deficient mice. Inflammation Research. 56(8). 339–344. 7 indexed citations
6.
Hegyesi, Hargita, Sára Tóth, Vieroslav Molnár, András Fülöp, & András Falus. (2007). Endogenous and exogenous histamine influences on angiogenesis related gene expression of mice mammary adenocarcinoma. Inflammation Research. 56(S1). S37–S38. 5 indexed citations
7.
Budai, Marianna, Anne Reynaud-Angelin, Z Szabó, et al.. (2004). Effect of UVA radiation on membrane fluidity and radical decay in human fibroblasts as detected by spin labeled stearic acids. Journal of Photochemistry and Photobiology B Biology. 77(1-3). 27–38. 12 indexed citations
8.
9.
Polgar, A. A., et al.. (2002). A synthetic corticosteroid, dexamethasone regulates generation of soluble form of interleukin-6 receptor of human lymphocytes, in vitro. Acta Biologica Hungarica. 53(3). 307–315. 4 indexed citations
10.
Lázár‐Molnár, Eszter, Hargita Hegyesi, Éva Pállinger, et al.. (2002). Inhibition of human primary melanoma cell proliferation by histamine is enhanced by interleukin‐6. European Journal of Clinical Investigation. 32(10). 743–749. 37 indexed citations
11.
Igaz, Péter, Sára Tóth, & András Falus. (2001). Biological and clinical significance of the JAK-STAT pathway; lessons from knockout mice. Inflammation Research. 50(9). 435–441. 100 indexed citations
12.
Igaz, Péter, Szilvia Bősze, Sára Tóth, András Falus, & Ferenc Hudecz. (2001). C-Terminal Peptides of Interleukin-6 Modulate the Expression of junB Protooncogene and the Production of Fibrinogen by HepG2 Cells. Biological Chemistry. 382(4). 669–676. 2 indexed citations
13.
Hegyi, Krisztina, András Fülöp, Sára Tóth, et al.. (2001). Histamine deficiency suppresses murine haptoglobin production and modifies hepatic protein tyrosine phosphorylation. Cellular and Molecular Life Sciences. 58(5). 850–854. 13 indexed citations
14.
Molnár, Eszter, Hargita Hegyesi, Sára Tóth, et al.. (2000). Biosynthesis of interleukin-6, an autocrine growth factor for melanoma, is regulated by melanoma-derived histamine. Seminars in Cancer Biology. 10(1). 25–28. 22 indexed citations
15.
Igaz, Péter, Barbara Horváth, Csaba Szalai, et al.. (2000). Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production. Immunology Letters. 71(3). 143–148. 20 indexed citations
16.
Tóth, Sára, et al.. (2000). Exon–intron organization of the human gp130 gene. Gene. 243(1-2). 161–166. 5 indexed citations
17.
18.
Igaz, Péter, Sára Tóth, & G. Csaba. (1995). Long-lasting persistence of elevated sister-chromatid exchange frequencies induced by perinatal benzo(a)pyrene treatment in rat bone-marrow cells. Cellular and Molecular Life Sciences. 51(6). 612–615. 1 indexed citations
19.
Tóth, Sára, et al.. (1989). Decreased cytosolic free calcium concentration of aged human lymphocytes in resting state.. PubMed. 3 Suppl. 16–22. 5 indexed citations
20.
Tóth, Sára & G. Csaba. (1988). γ-l-Glutamyl-taurine (Litoralon®) prevents the micronucleus formation induced by mitomycin C. Mutation Research Letters. 209(1-2). 85–89. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karsten Jürchott Breakdown of academic impact, for papers by Toru Tanaka Breakdown of academic impact, for papers by Gautam Adhikary Breakdown of academic impact, for papers by Lazaros C. Foukas Breakdown of academic impact, for papers by Masahito Matsumoto Breakdown of academic impact, for papers by Xuejie Wang Breakdown of academic impact, for papers by Danielle L. Krebs Breakdown of academic impact, for papers by Osvaldo Rey Breakdown of academic impact, for papers by Michele C. Madigan Breakdown of academic impact, for papers by Nassim Ghaffari‐Tabrizi‐Wizsy
Rankless by CCL
2026